- Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus infection. Lancet 1981; ii: 1129–32.
- Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987; 47: 4967–72.
- Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non-A, non-B virus hepatitis genome. Science 1989; 244: 359–62.
- Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671–5.
- Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992; 15: 948–63.
- Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients. Hepatology 1995; 21: 650–5.
- Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391–9.
- Widell A, Shev S, Månsson S, Zhang YY, Foberg U, Norkrans G, et al. Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: Epidemiological applications. J Med Virol 1994; 44: 272–9.
- Tanaka K, Ikematsu H, Hirohata T, Kashiwagi S. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1 b (II) infection. J Natl Cancer Inst 1996; 88: 742–6.
- Silini E, Bottelli R, Asti M, Bruno S, Candusso ME, Brambilla S, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterol 1996; 111: 199–205.
- Bruno S, Silini E, Crosignani A, Borzio F, Leandro G, Bono F, et al. Hepatitis C virus genotypes and the risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997; 25: 754–8.
- Poynard T, Bedossa P, Opolon P for the OBSVIRC, METAVIR; CLINIVIR and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825–32.
- Benvegnù L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Alberti A. Lack of correlation between hepatitis C virus genotypes and the clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997; 25: 211–5.
- Nousbaum J-B, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122: 161–8.
- Kaczynski J, Hansson G, Wallerstedt S. Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area. Br J Cancer 1996; 73: 128–32.
- Kaczynski J, Hansson G, Hermodsson S, Olsson R, Wallerstedt S. Minor role of hepatitis B and C virus infection in the aetiology of hepatocellular carcinoma in a low-endemic area. Scand J Gastroenterol 1996; 31: 809–13.
- Verbaan H, Widell A, Lindgren S, Lindmark B, Nordenfelt E, Eriksson S. Hepatitis C in chronic liver disease: an epidemiological study based on 566 consecutive patients undergoing liver biopsy during a 10-year period. J Intern Med 1992; 232: 33–42.
- Verbaan H, Hoffmann G, Lindgren S, Nilsson S, Widell A, Eriksson S. Long-term outcome of chronic hepatitis C infection in a low-prevalence area. Scand J Gastroenterol 1998; 33: 650–5.
- Wejstal R, Widell A, Norkrans G. Hepatitis C virus infection with progression to hepatocellular carcinoma: A report of five prospectively followed patients in Sweden. Scand J Infect Dis 1993; 25: 417–20.
- Ljunggren K, Kidd AH. Enzymatic amplification and sequence analysis of precore/core DNA in HBsAg-positive patients. J Med Virol 1991; 34: 179–83.
- Widell A, Månsson AS, Sundström G, Hansson BG, Nordenfelt. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: Comparison with supplementary hepatitis C antibody assays. J Med Virol 1991; 35: 253–8.
- Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994; 74: 2442–8.
- Hadziyannis S, Tabor E, Kaklamani E, Tzonou A, Stuver S, Tassopoulos N, et al. A case-control study of hepatitis B and C virus infections in the aetiology of hepatocellular carcinoma. Int J Cancer 1995; 60: 627–31.
- Tsai J-F, Jeng J-E, Ho M-S, Chang W-Y, Lin Z-Y, Tsai J-H. Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: A case-control study. Int J Cancer 1994; 56: 619–21.
- Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, et al. Characteristic difference of hepatocellular carcinoma between hepatitis Band C-viral infection in Japan. Hepatology 1995; 22: 1027–33.
- Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis: A case-control study. Ann Intern Med 1992; 116: 97–102.
- Takada S, Kaneniwa N, Tsuchida N, Koike K. Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumour suppressor gene product in the transient expression system. Virology 1996; 216: 80–9.
- Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995; 69: 3893–6.
- Park YN, Abe K, Li H, Hsuih T, Thung SN, Zhang DY. Detection of hepatitis C virus RNA using ligation-dependent polymerase chain reaction in formalin-fixed, paraffin-embedded liver tissues. Am J Pathol 1996; 149: 1485–91.
- The Cancer Registry, Centre for Epidemiology. Cancer incidence in Sweden 1958–1979 Stockholm: National Board of Health and Welfare, 1982.
- Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, et al. The origin of hepatitis C virus genotypes. J Gen Virol 1996; 78: 321–8.
Hepatocellular Carcinoma in Sweden: its Association with Viral Hepatitis, Especially with Hepatitis C Viral Genotypes
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.